Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Healthcare & EM Bonds: 2 ETFs To Watch On Outsized Volume

Published 06/21/2018, 08:37 AM
Updated 07/09/2023, 06:31 AM

In the last trading session, U.S. stocks were mixed. Among the top ETFs, investors saw (AX:SPY) gain 0.2%, (V:DIA) lose 0.2%, and QQQ move higher by about 0.7% on the day.

Two more specialized ETFs are worth noting as both saw trading volume that was far outside of normal. In fact, both these funds experienced volume levels that were more than double their average for the most recent trading session. This could make these ETFs the ones to watch out for in the days ahead to see if this trend of extra-interest continues:

(HN:PTH) : Volume 3.97 times average

This financial ETF was in the spotlight on Wednesday as about 83,012 shares moved hands compared with an average of 20,900 shares a day. We also saw some price movement as PTH gained about 1.7% last session.

Overall, the healthcare sector is upbeat. The sector’s non-cyclical nature probably has helped it to rule out market jitters emanating from trade tensions. PTH has jumped 9.6% in the past month.

(TO:PCY) : Volume 3.48 times average

This emerging market sovereign debt ETF was under the microscope on Wednesday as nearly 5.8 million shares moved hands. This compares with an average trading day of roughly 1.7 million shares and came as PCY gained about 0.2% in the trading session. The fund has lost about 1.7% in a month’s time. The movement can largely be credited to growing pain in the emerging market space thanks to rising rates in the United States.

Want key ETF info delivered straight to your inbox?

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>



SPDR-DJ IND AVG (DIA): ETF Research Reports

NASDAQ-100 SHRS (QQQ): ETF Research Reports

SPDR-SP 500 TR (SPY (NYSE:SPY

PWRSH-DW HLT MO (PTH): ETF Research Reports

PWRSH-EM SVN DP (PCY): ETF Research Reports

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.